Home
overview
The SMi Group's 3rd Annual Pricing and Reimbursement in North America Conference comes at an exciting and crucial time. With the introduction of Medicare Part D in 2006 combined with a party leadership change in Congress, North American Pricing and Reimbursement is currently undergoing one of its most dramatic periods in its history.
Senior figures from the pharmaceutical industry will explore the initial results of Medicare Part D from a pharma, payer and patient perspective, as well as contextualising North America within the Global Pricing and Reimbursement scene. Also included are keynote presentations on the importance of Parallel Trade and reimbursement of high-priced medication making the SMi Group's North American Pricing and Reimbursement Conference a necessary and unmissable event.
Don't miss the opportunity to listen to an excellent speaker panel, including:
  • Anne-Toni Rodgers, Director, Government Affairs and Public Policy, Europe, Baxter World Trade
  • Neil Palmer, Vice President, Pricing & Reimbursement, RTI Health Solutions
  • Curtis Moore, Manager, Global Sales & Price Operations, Genzyme
  • Kathy Hughes, Vice President & Director, Consulting Operations, Covance Market Access Services
  • Ted Sweeney, Partner, PriceSpective
  • Donald Zowader, Manager, Government Affairs, Takeda
  • Dr Boris Simkovich, President, Light Management Consultancy LLC
  • Gary Johnson, Managing Director, Inpharmation

This is an excellent forum for you to meet with an international selection of the industry’s key players to hear expert perspectives discussing:

  • THE AFTER EFFECTS and impact upon the industry of the changing landscape in North American pricing and reimbursement
  • EFFECTIVE approaches to working with regional pricing agencies whilst maintaining a global strategy
  • WHAT is happening in regard to coverage, reimbursement, and general management of very high priced medication?
  • A COMPARATIVE analysis of the expanding EU, USA and other foreign markets
  • FUTURE pricing scenarios in North America
  • HOW the North American market affects the global pharma industry

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Boris Simkovich

Boris Simkovich, President, Light Management Consulting LLC

9:10 KEYNOTE OPENING ADDRESS

Boris Simkovich

Boris Simkovich, President, Light Management Consulting LLC

  • The current pricing and reimbursement structure in North America
  • Potential changes in the U.S. P&R system
    - Who are the key stakeholders and influencers?
    - How will the change in party leadership affect the P&R system?
  • The impact of European P&R reforms on the North American market
  • 9:50 WORKING WITH LOCAL REGULATORS WHILST MAINTAINING AN INTERNATIONAL STRATEGY

    Anne-Toni Rodgers

    Anne-Toni Rodgers, Director, Government Affairs & Public Policy Europe, Baxter World Trade S. A

    10:30 Morning Coffee

    11:00 STATE MEDICAID

    Donald Zowader

    Donald Zowader, Manager, Government Affairs, Takeda Pharmaceuticals

  • Effects of Medicare Part D in the market
  • The move from Medicaid to Medicare - and how that may and will affect reimbursement and pricing?
  • How have changes affected the pharmaceutical industry?
  • The impact of Medicare Part D had on state insurance programs, including Medicaid, state drug assistance plans, and other programs?
  • 12:20 Networking Lunch

    13:50 FUTURE PRICING SCENARIOS IN THE USA

    Deborah Williams

    Deborah Williams, Director, Government Affairs and Public Policy, Baxter Healthcare Corporation

  • What types of moves will the Democrats make that the Republicans have not made?  
  • Will there continue to be a non-interference policy in the Medicare Part-D legislation that precludes direct governmental negotation with drug manufacturers? 
  • The effect of the public relese of Average Manufacturers Price AMP data and other Deficit Reduction Act provision of 2005 as well as transparency legislation on
  • 15:10 Afternoon Tea

    15:40 PRICING IMPLICATIONS FOR PHYSICIAN-ADMINISTERED PRODUCTS

    Ted Sweeney

    Ted Sweeney, Partner, PriceSpective

    17:00 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Boris Simkovich

    Boris Simkovich, President, Light Management Consulting LLC

    9:10 EUROPE, NORTH AMERICA AND BEYOND

    Gary Johnson

    Gary Johnson, Managing Director, Inpharmation

  • What are the main differences between US and European pricing and reimbursement structures?
  • What can we learn from other markets – for example, Japan?
  • How does the pricing of drugs within the European market affect the price in North America?
  • How the P&R environment change in light of an expanding Europe
  • 9:50 MEDICARE PART D: A MOVE TOWARDS COST CONTROL FOR DRUGS?

    Curtis Moore

    Curtis Moore, Manager, Global Sales & Price Operations, Genzyme Corporation

  • What approaches have been taken in EU  (e.g. reference prices)
  • Difference between EU system and US system
  • Strategies for pharma moving forwards
  • 10:30 Morning Coffee

    11:00 THE CANADIAN PERSPECTIVE

    Neil Palmer

    Neil Palmer, Vice President, Pricing & Reimbursement, RTI Health Solutions

  • What are the main differences between the US and Canada?
  • Canadian price regulation and the Patented Medicine Prices Review Board (PMPRB)
  • Canadian reimbursement schemes and the impact of the Common Drug Review (CDR)
  • Optimizing market access in Canada while respecting global pricing bands
  • Canadian price increases: An endangered species?
  • Impact of US Medicare Part D on Canada – impact of Canadian prices on the U.S.
  • Prospects for Canada/US cross-border trade & re-importation
  • The price gap between Canada, Europe and the United States – what are the implications?
  • Canadian outlook: integration of government pricing & reimbursement schemes?
  • 11:40 OPTIMISING MARKET ACCESS IN NORTH AMERICA

    Pamela Santoni

    Pamela Santoni, Senior Principal, IMS Health

  • How have benefit designs evolved, and what are the implications for pharmaceutical manufacturers?
  • What are the main barriers hindering access to the North American market?
  • What are typical formulary management tools and philosophies and how are they impacting access?
  • What strategies have proved to be successful in the evolving marketplace?
  • 12:20 Networking Lunch

    13:50 GOVERNMENTAL BUYING POWER

    Scott Roberts

    Scott Roberts, Director, PriceSpective

    14:30 THE IMPORTANCE OF “GOOD SCIENCE” TO REIMBURSEMENT

  • Quality and revenue are no longer separate issues the industry
  • What can we expect in this arena? 
  • Is the US becoming more like the rest of the world in requiring that the "value" of new and existing drug products be demonstrated?
  • Developing an agile communications strategy that highlights a product’s benefits
  • Kathleen Hughes

    Kathleen Hughes, Vice President & Director of Consulting Operations, Covance

    Meridith Johnson

    Meridith Johnson, Senior Associate, Covance

    15:10 Afternoon Tea and Close of Conference

    +

    Workshops

    Achieving Pricing & Reimbursement Success in the USA Market
    Workshop

    Achieving Pricing & Reimbursement Success in the USA Market

    Crowne Plaza Hotel - The City
    6th June 2007
    London, United Kingdom

    Crowne Plaza Hotel - The City

    19 New Bridge Street
    London EC4V 6DB
    United Kingdom

    Crowne Plaza Hotel - The City

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.